MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Journal of gastroenterology

• Publication date

  2024-05-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00535-024-02115-wPMID 38739200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents

  2023influential reference
• Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus

  2023cited by this paper
• Clinical impact of bile‐derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers

  2022cited by this paper
• Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis

  2022cited by this paper
• Serum angiopoietin‐2 levels predict regression of Mac‐2 binding protein glycosylation isomer‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents

  2022influential reference
• MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury

  2022cited by this paper
• MiR-223 as a Regulator and Therapeutic Target in Liver Diseases

  2022influential reference
• Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases

  2021cited by this paper
• MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types

  2021cited by this paper
• Co-continuous structural effect of size-controlled macro-porous glass membrane on extracellular vesicle collection for the analysis of miRNA

  2021influential reference
• Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA

  2021cited by this paper
• Extracellular vesicles from tonsil-derived mesenchymal stromal cells show anti-tumor effect via miR-199a-3p

  2021cited by this paper
• Pericyte-derived extracellular vesicles-mimetic nanovesicles improves peripheral nerve regeneration in mouse models of sciatic nerve transection

  2021cited by this paper
• Stratification of Residual Risk of HCC Following HCV Clearance With Direct‐Acting Antivirals in Patients With Advanced Fibrosis and Cirrhosis

  2020cited by this paper
• Rapid and label-free isolation of small extracellular vesicles from biofluids utilizing a novel insulator based dielectrophoretic device.

  2019cited by this paper
• Presence of varices in patients after hepatitis C virus eradication predicts deterioration in the FIB‐4 index

  2019cited by this paper
• Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223.

  2019cited by this paper
• Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C

  2018cited by this paper
• Treatment of hepatitis C in special populations

  2018cited by this paper
• Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.

  2018cited by this paper
• Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

  2018cited by this paper
• High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome Metabolomics.

  2018cited by this paper
• Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

  2018cited by this paper
• Magnetic-Based Microfluidic Device for On-Chip Isolation and Detection of Tumor-Derived Exosomes.

  2018cited by this paper
• Role of miR-223 in the pathophysiology of liver diseases

  2018cited by this paper
• Cancer exosomes induce tumor innervation

  2018cited by this paper
• FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin

  2018cited by this paper
• Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer

  2017cited by this paper
• Hypothalamic stem cells control aging speed partly through exosomal miRNAs

  2017cited by this paper
• Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis

  2017cited by this paper
• Serum WFA+‐M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection

  2017cited by this paper
• The Exosome Total Isolation Chip.

  2017cited by this paper
• Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C

  2016cited by this paper
• Isolation and mass spectrometry analysis of urinary extraexosomal proteins

  2016cited by this paper
• Role of assessing liver fibrosis in management of chronic hepatitis C virus infection.

  2016cited by this paper
• Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysis

  2015cited by this paper
• Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response

  2015influential reference
• Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma

  2015cited by this paper
• Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease

  2015cited by this paper
• Circulating microRNAs: Emerging Biomarkers of Liver Disease

  2015cited by this paper
• Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.

  2015influential reference
• Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells

  2015cited by this paper
• The emerging roles of microvesicles in liver diseases

  2014cited by this paper
• Clinical relevance of circulating cell-free microRNAs in cancer

  2014cited by this paper
• Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

  2014influential reference
• Full-Length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells

  2012cited by this paper
• Microparticles: major transport vehicles for distinct microRNAs in circulation

  2012cited by this paper
• Comprehensive miRNA Expression Analysis in Peripheral Blood Can Diagnose Liver Disease

  2012cited by this paper
• Investigation of the freely available easy-to-use software ‘EZR' for medical statistics

  2012influential reference
• Detection of microRNA Expression in Human Peripheral Blood Microvesicles

  2008cited by this paper
• Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

  2007cited by this paper

• Regression of fibrosis and portal hypertension in chronic liver disease: Endothelial perspectives and clinical implications.

  2026cites this paper